Biosimilars are a
prescription for
better health.

In the U.S., Biosimilars could lead to over $130 billion is savings by 2025, and have been used in over 120 million days of patient therapy.

There are covid 19 vaccines and a gavel on the white table.

BsUFA Reauthorization

This year, Congress will consider the third version of The Biosimilar User Fee Act (BsUFA), which will modernize and streamline the biosimilar review process. It is imperative that Congress reauthorize BsUFA. Learn More.

Washington D.C., District of Columbia, United States - August 31 2021: The Federal Trade Commission FTC of the United States of America logo. Enforcing the rule of law in trade.

The FTC Must Investigate Pharmacy Benefit Managers!

Pharmacy benefit manager business practices too often deprive patients of lower cost biosimilar options and can, in fact, increase costs. Read our letter urging the FTC to investigate. Learn more.


The Biosimilars Council advocates to increase patient access to lifesaving, affordable biosimilar medicines.

Our members include manufacturers and stakeholders working to develop biosimilar medicines for the U.S. market


Biosimilars approved in the U.S.


Billion in potential savings for patients and payers


Million days of patient therapy where biosimilars were used


Million additional days of patient therapy

The Benefits of Biosimilars

Expanding access to biosimilars has proven successful in driving down the cost of life-saving therapies.

This increases access to needed medications for patients, strengthens our economy and benefits our society.

View resources for:

Recent Blogs & Resources

What Patients Are Saying

Expanding access to biosimilars has proven successful in driving down the cost of life-saving therapies.
, Biosimilars Council

“Because I have an incurable form of non-Hodgkin lymphoma, I know my medication journey will continue. It is nice to know that when I need a biosimilar again, it will be there for me.”

Helen, 41, Florida

Listen to their stories.

You Can Make A Difference

As the role of biosimilar medicines in our health care system continues to grow, it is essential that patients advocate for affordable biosimilars with their lawmakers. Subscribe to the Biosimilars Bulletin and for alerts on policies that affect your access to these life-saving medicines.

  • This field is for validation purposes and should be left unchanged.

Recent Tweets

Delusions of being an animal, a person with few words, and medicines achieving their intended results... must be another #FamiliarFriday!

Watch our latest video and see if you can choose the #biosimilar term!

#WordoftheWeek #biosimilarfamiliar

Load More...